RENDIMIENTO DIAGNÓSTICO DE UN SISTEMA MOLECULAR DE USO EN EL PUNTO DE ATENCIÓN PAR A LA DETECCIÓN DE SARS-CoV-2 EN PERÚ

Translated title of the contribution: DIAGNOSTIC PERFORMANCE OF A POINT-OF-CARE MOLECULAR SYSTEM FOR THE DETECTION OF SARS-COV-2 IN PERU

Zully M. Puyén, Roger Araujo-Castillo, Jorge Giraldo, Karina Gutierrez, Nancy Rojas-Serrano

Research output: Contribution to journalArticlepeer-review

Abstract

The present study assessed the diagnostic performance of the Xpert®Xpress SARS-CoV-2 test in comparison with the Charité protocol real-time RT PCR for the detection of SARS-CoV-2 in Peruvian patients. This was a diagnostic test study that included 100 nasal and pharyngeal swab samples. We obtained an overall concordance of 98.70% (95%CI: 92.98-99.97), with a kappa coefficient of 0.97 (95%CI: 0.86-1.00) and sensitivity and relative specificity rates of 100% and 96.15%, respectively. Additionally, the percentage of the area under the ROC curve was 98.08% in both cases, and an analytical specificity rate of 100% was obtained for the different respiratory viruses evaluated. In conclusion, the Xpert®Xpress SARS-CoV-2 test, by using nasal and pharyngeal swab samples, was highly sensitive and specific, and the kappa coefficient showed an excellent correlation when compared to the reference test.

Translated title of the contributionDIAGNOSTIC PERFORMANCE OF A POINT-OF-CARE MOLECULAR SYSTEM FOR THE DETECTION OF SARS-COV-2 IN PERU
Original languageSpanish
Pages (from-to)76-82
Number of pages7
JournalRevista Peruana de Medicina Experimental y Salud Publica
Volume41
Issue number1
DOIs
StatePublished - 1 Jan 2024

Fingerprint

Dive into the research topics of 'DIAGNOSTIC PERFORMANCE OF A POINT-OF-CARE MOLECULAR SYSTEM FOR THE DETECTION OF SARS-COV-2 IN PERU'. Together they form a unique fingerprint.

Cite this